![Medicare Expands Coverage of Molecular Cancer Screening Tests](https://www.g2intelligence.com/wp-content/uploads/2023/05/May23.LIR_.MedicareGeneticTestCoverage-iStock-1169304873-1100x800-1-1080x675.jpg)
Medicare Expands Coverage of Molecular Cancer Screening Tests
In terms of Medicare coverage, 2023 is shaping up to be a fruitful year—here are five of the most significant approvals so far.
In terms of Medicare coverage, 2023 is shaping up to be a fruitful year—here are five of the most significant approvals so far.
Auditing in medical laboratories is critical for reviewing processes to identify erroneous outcomes, as well as areas for improvement.
Labs must use the new Advance Beneficiary Notice of Noncoverage (ABN) form starting on June 30, 2023, when the old version expires.
On March 28, the 118th Congress raised lab industry hopes once more by reintroducing the Saving Access to Laboratory Services Act (SALSA).
New legislation would force CMS to change the way it calculates Medicare prices for lab tests.